文献速递肾血管病与高血压慢性肾脏病遗传性与小管间质肾病

肾单位特异性多囊蛋白-1缺失通过环氧合酶-2介导血压降低且不依赖囊肿形成

Nephron-Specific Disruption of Polycystin-1 Induces Cyclooxygenase-2-Mediated Blood Pressure Reduction Independent of Cystogenesis.
PubMed 文献 · J Am Soc Nephrol · 2020-04-16

在3月龄小鼠诱导肾单位特异性Pkd1基因破坏,4-5月龄时观察。Pkd1敲除小鼠肾脏无囊肿、小管扩张或细胞增殖增加,高盐摄入时动脉压降低,伴利钠、利尿和利钾反应增强,尿PGE2排泄显著增加,COX-2蛋白升高,COX-2抑制剂NS-398消除血压差异。提示肾单位多囊蛋白-1缺陷本身不导致ADPKD高血压,反而可能具有相对排盐效应。

要点

  • 肾单位Pkd1缺失小鼠无囊肿形成,高盐时血压降低而非升高。
  • 低血压与尿PGE2排泄增加及COX-2蛋白升高相关,COX-2抑制剂可消除差异。
  • 肾单位多囊蛋白-1缺陷本身不贡献ADPKD高血压,可能起排盐作用。

核心结论

  • 肾单位多囊蛋白-1缺陷本身不导致ADPKD高血压,可能具有相对排盐效应。

研究设计与样本

  • 在3月龄小鼠诱导肾单位特异性Pkd1基因破坏,4-5月龄时检查。

主要发现

  • Pkd1敲除小鼠肾脏无 apparent 肾囊肿、小管扩张或细胞增殖增加。
  • 高盐摄入时Pkd1敲除小鼠动脉压降低,伴利钠、利尿和利钾反应增强。
  • Pkd1敲除小鼠尿PGE2排泄显著增加,尿亚硝酸盐/硝酸盐排泄降低,GFR、血浆肾素浓度和尿内皮素-1排泄与对照相似。
  • 高盐时Pkd1敲除小鼠肾脏COX-2蛋白水平升高,NS-398消除血压差异。
  • 高盐饮食下Pkd1敲除小鼠肾脏NKCC2水平大幅降低。

临床怎么用

  • 提示ADPKD高血压可能并非由肾单位多囊蛋白-1缺失直接驱动,需关注其他机制。
  • 肾单位多囊蛋白-1在无囊肿时可能参与血压和钠排泄调节。

局限性

  • 研究为小鼠模型,结果外推至人类ADPKD需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertension often occurs before renal function deteriorates in autosomal dominant polycystic kidney disease (ADPKD). It is unknown whether the Pkd1 gene product polycystin-1-the predominant causal factor in ADPKD-itself contributes to ADPKD hypertension independent of cystogenesis. METHODS: We induced nephron-specific disruption of the Pkd1 gene in 3-month-old mice and examined them at 4-5 months of age. RESULTS: Kidneys from the Pkd1 knockout mice showed no apparent renal cysts, tubule dilation, or increased cell proliferation. Compared with control mice, Pkd1 knockout mice exhibited reduced arterial pressure during high salt intake; this associated with an increased natriuretic, diuretic, and kaliuretic response during the first 2-3 days of salt loading. The lower arterial pressure and enhanced natriuresis during high salt loading in Pkd1 knockout mice were associated with lower urinary nitrite/nitrate excretion and markedly increased urinary PGE2 excretion, whereas GFR, plasma renin concentration, and urinary endothelin-1 excretion were similar between knockout and control mice. Kidney cyclooxygenase-2 protein levels were increased in Pkd1 knockout mice during high salt intake; administration of NS-398, a selective cyclooxygenase-2 inhibitor, abolished the arterial pressure difference between the knockout and control mice during high salt intake. Total kidney Na+/K+/2Cl- cotransporter isoform 2 (NKCC2) levels were greatly reduced in Pkd1 knockout mice fed a high salt diet compared with controls. CONCLUSIONS: These studies suggest that nephron polycystin-1 deficiency does not itself contribute to ADPKD hypertension and that it may, in fact, exert a relative salt-wasting effect. The work seems to comprise the first in vivo studies to describe a potential physiologic role for nephron polycystin-1 in the absence of cysts, tubule dilation, or enhanced cell proliferation.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Lakshmipathi J, Gao Y, Hu C, et al. Nephron-Specific Disruption of Polycystin-1 Induces Cyclooxygenase-2-Mediated Blood Pressure Reduction Independent of Cystogenesis. J Am Soc Nephrol. 2020. PMID: 32300065. doi:10.1681/ASN.2019090934

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。